Fluorescence-guided surgery and intervention — An AAPM emerging technology blue paper
Pogue BW, Zhu TC, Ntziachristos V, Paulsen KD, Wilson BC, Pfefer J, Nordstrom RJ, Litorja M, Wabnitz H, Chen Y, Gioux S, Tromberg BJ, Yodh AG (2018)
Publication Type: Journal article
Publication year: 2018
Journal
Book Volume: 45
Pages Range: 2681-2688
Journal Issue: 6
DOI: 10.1002/mp.12909
Abstract
Fluorescence-guided surgery (FGS) and other interventions are rapidly evolving as a class of technologically driven interventional approaches in which many surgical specialties visualize fluorescent molecular tracers or biomarkers through associated cameras or oculars to guide clinical decisions on pathological lesion detection and excision/ablation. The technology has been commercialized for some specific applications, but also presents technical challenges unique to optical imaging that could confound the utility of some interventional procedures where real-time decisions must be made. Accordingly, the AAPM has initiated the publication of this Blue Paper of The Emerging Technology Working Group (TETAWG) and the creation of a Task Group from the Therapy Physics Committee within the Treatment Delivery Subcommittee. In describing the relevant issues, this document outlines the key parameters, stakeholders, impacts, and outcomes of clinical FGS technology and its applications. The presentation is not intended to be conclusive, but rather to inform the field of medical physics and stimulate the discussions needed in the field with respect to a seemingly low-risk imaging technology that has high potential for significant therapeutic impact. This AAPM Task Group is working toward consensus around guidelines and standards for advancing the field safely and effectively.
Involved external institutions
Dartmouth College
United States (USA) (US)
University of Pennsylvania (UPenn)
United States (USA) (US)
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (HMGU) / Helmholtz Munich
Germany (DE)
University of Toronto
Canada (CA)
Food and Drug Administration (FDA / USFDA)
United States (USA) (US)
National Cancer Institute (NCI)
United States (USA) (US)
National Institute of Standards and Technology (NIST)
United States (USA) (US)
Physikalisch-Technische Bundesanstalt (PTB)
Germany (DE)
University of Maryland, College Park (UMD)
United States (USA) (US)
Harvard University
United States (USA) (US)
University of California Irvine
United States (USA) (US)
United States (USA) (US)
University of Pennsylvania (UPenn)
United States (USA) (US)
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (HMGU) / Helmholtz Munich
Germany (DE)
University of Toronto
Canada (CA)
Food and Drug Administration (FDA / USFDA)
United States (USA) (US)
National Cancer Institute (NCI)
United States (USA) (US)
National Institute of Standards and Technology (NIST)
United States (USA) (US)
Physikalisch-Technische Bundesanstalt (PTB)
Germany (DE)
University of Maryland, College Park (UMD)
United States (USA) (US)
Harvard University
United States (USA) (US)
University of California Irvine
United States (USA) (US)
How to cite
APA:
Pogue, B.W., Zhu, T.C., Ntziachristos, V., Paulsen, K.D., Wilson, B.C., Pfefer, J.,... Yodh, A.G. (2018). Fluorescence-guided surgery and intervention — An AAPM emerging technology blue paper. Medical Physics, 45(6), 2681-2688. https://doi.org/10.1002/mp.12909
MLA:
Pogue, Brian W., et al. "Fluorescence-guided surgery and intervention — An AAPM emerging technology blue paper." Medical Physics 45.6 (2018): 2681-2688.
BibTeX: Download